Tech Company Financing Transactions
Cytori Therapeutics Funding Round
GE Healthcare Financial Services and Silicon Valley Bank invested in a $15 million funding round for Cytori Therapeutics. The round closed on 10/15/2008.
Transaction Overview
Company Name
Announced On
10/15/2008
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
GE Healthcare Financial Services (Lead Investor) (Anthony Storino)
Proceeds Purpose
The investment will be used to support the commercialization of Cytori's recently launched Celution® System and StemSource® Cell Bank in Europe and Asia. In addition, the funds will support product pipeline development and general corporate activities. Securing this loan facility further demonstrates Cytori's ability to attract funding from well regarded sources.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
3020 Callan Rd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cytori Therapeutics' (Nasdaq: CYTX) goal is to be the global leader in regenerative medicine. Cytori is dedicated to providing patients with new options for reconstructive and aesthetic surgery, developing treatments for cardiovascular disease, and banking patients' adipose-derived, adult stem and regenerative cells (ADRCs).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marc Hedrick
Chief Financial Officer
Tiago Girao
Chief Medical Officer
Steven Kesten
Chief Scientific Officer
John Fraser
Browse more venture capital transactions:
Prev: 10/14/2008: LimoRes.net venture capital transaction
Next: 10/15/2008: JS-Kit venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs